Semi-Annual Balance Sheet

JCR Pharmaceuticals Co.,Ltd. - Filing #7350553

Concept As at
2023-12-31
As at
2023-03-31
Semi-annual balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
18,301,000,000 JPY
13,278,000,000 JPY
Other
2,055,000,000 JPY
4,870,000,000 JPY
Current assets
57,468,000,000 JPY
47,802,000,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
30,657,000,000 JPY
32,681,000,000 JPY
Land
10,587,000,000 JPY
10,379,000,000 JPY
Construction in progress
121,000,000 JPY
13,008,000,000 JPY
Other
Other, net
5,561,000,000 JPY
2,165,000,000 JPY
Intangible assets
Intangible assets
3,609,000,000 JPY
3,652,000,000 JPY
Patent right
2,227,000,000 JPY
2,434,000,000 JPY
Other
1,381,000,000 JPY
1,217,000,000 JPY
Investments and other assets
Investment securities
9,251,000,000 JPY
8,867,000,000 JPY
Investments and other assets
11,038,000,000 JPY
10,800,000,000 JPY
Other
1,791,000,000 JPY
1,938,000,000 JPY
Allowance for doubtful accounts
-4,000,000 JPY
-4,000,000 JPY
Non-current assets
45,304,000,000 JPY
47,135,000,000 JPY
Assets
102,773,000,000 JPY
94,937,000,000 JPY
Liabilities
Current liabilities
Accounts payable - trade
1,567,000,000 JPY
1,563,000,000 JPY
Short-term borrowings
9,700,000,000 JPY
16,800,000,000 JPY
Income taxes payable
1,950,000,000 JPY
33,000,000 JPY
Other
6,091,000,000 JPY
3,779,000,000 JPY
Current liabilities
31,914,000,000 JPY
35,762,000,000 JPY
Non-current liabilities
Non-current liabilities
14,910,000,000 JPY
6,761,000,000 JPY
Long-term borrowings
13,600,000,000 JPY
5,500,000,000 JPY
Other
248,000,000 JPY
241,000,000 JPY
Liabilities
46,824,000,000 JPY
42,523,000,000 JPY
Other liabilities
Provision for bonuses
521,000,000 JPY
974,000,000 JPY
Other liabilities
Provision for bonuses for directors (and other officers)
86,000,000 JPY
114,000,000 JPY
Net assets
Shareholders' equity
Share capital
9,061,000,000 JPY
9,061,000,000 JPY
Capital surplus
Capital surplus
10,384,000,000 JPY
10,384,000,000 JPY
Retained earnings
Retained earnings
36,933,000,000 JPY
34,273,000,000 JPY
Treasury shares
-2,964,000,000 JPY
-2,978,000,000 JPY
Shareholders' equity
53,414,000,000 JPY
50,740,000,000 JPY
Valuation and translation adjustments
Valuation difference on available-for-sale securities
653,000,000 JPY
555,000,000 JPY
Deferred gains or losses on hedges
0 JPY
JPY
Valuation and translation adjustments
1,426,000,000 JPY
681,000,000 JPY
Net assets
55,948,000,000 JPY
52,413,000,000 JPY
Share acquisition rights
812,000,000 JPY
740,000,000 JPY
Liabilities and net assets
102,773,000,000 JPY
94,937,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.